{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:23:16Z","timestamp":1791181396724,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2688,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Catholic University School of Medicine grants","award":["Linea D1-2012\/2013"],"award-info":[{"award-number":["Linea D1-2012\/2013"]}]},{"name":"Catholic University School of Medicine grants","award":["Linea D1 2012-70200996"],"award-info":[{"award-number":["Linea D1 2012-70200996"]}]},{"name":"Catholic University School of Medicine grants","award":["Linea D3.2 2013-70201169"],"award-info":[{"award-number":["Linea D3.2 2013-70201169"]}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1111\/jth.12967","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T06:57:20Z","timestamp":1429081040000},"page":"1226-1237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count"],"prefix":"10.1016","volume":"13","author":[{"given":"S.","family":"Lancellotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dragani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ranalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"De Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12967_bb0010","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2012-10-429134","article-title":"Platelet activation and inhibition in polycythemia vera and essential thrombocythemia","volume":"121","author":"Patrono","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0015","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2006-05-025544","article-title":"Management of extreme thrombocytosis in otherwise low\u2010risk essential thrombocythemia; does number matter?","volume":"108","author":"Tefferi","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/leu.2011.258","article-title":"Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria","volume":"26","author":"Finazzi","year":"2012","journal-title":"Leukemia"},{"key":"10.1111\/jth.12967_bb0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2012-04-424911","article-title":"Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort","volume":"120","author":"Campbell","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0035","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood.V68.6.1213.1213","article-title":"Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome","volume":"68","author":"Budde","year":"1986","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0040","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V82.6.1749.1749","article-title":"Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma","volume":"82","author":"Budde","year":"1993","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0045","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2141.1997.4823285.x","article-title":"Decreased half\u2010life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet count","volume":"99","author":"van Genderen","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12967_bb0050","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2141.1996.d01-1729.x","article-title":"The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count","volume":"93","author":"van Genderen","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12967_bb0055","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/j.seminhematol.2005.11.003","article-title":"Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders","volume":"43","author":"Federici","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1111\/jth.12967_bb0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.21946","article-title":"Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk\u2010stratification, and management","volume":"86","author":"Tefferi","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.12967_bb0065","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/leu.2013.99","article-title":"Personalized management of essential thrombocythemia\u2010application of recent evidence to clinical practice","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"key":"10.1111\/jth.12967_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ajh.23417","article-title":"Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk\u2010stratification, and management","volume":"88","author":"Tefferi","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.12967_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis","volume":"63","author":"Fabris","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12967_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2007-05-093021","article-title":"Platelet\u2010VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress","volume":"111","author":"Shim","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0085","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2009-01-195461","article-title":"Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site","volume":"114","author":"Raife","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0090","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1538-7836.2011.04367.x","article-title":"Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from ADAMTS\u201013","volume":"9","author":"Lancellotti","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0095","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear\u2010dependent changes in the three\u2010dimensional structure of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0100","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.bpj.2008.12.3900","article-title":"Fluid shear induces conformation change in human blood protein von Willebrand factor in solution","volume":"96","author":"Singh","year":"2009","journal-title":"Biophys J"},{"key":"10.1111\/jth.12967_bb0105","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1170905","article-title":"Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor","volume":"324","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"10.1111\/jth.12967_bb0110","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1073\/pnas.0608422104","article-title":"Shear\u2010induced unfolding triggers adhesion of von Willebrand factor fibers","volume":"104","author":"Schneider","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12967_bb0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<153::AID-AJH15>3.0.CO;2-Z","article-title":"Normal binding of plasma von Willebrand factor to platelets in essential thrombocythemia","volume":"61","author":"van Genderen","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.12967_bb0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1160\/TH13-10-0844","article-title":"In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia","volume":"112","author":"Cavalca","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0125","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.thromres.2011.11.021","article-title":"Modulation of the von Willebrand factor\u2010dependent platelet adhesion through alternative proteolytic pathways","volume":"129","author":"Wohner","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12967_bb0130","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0135","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0140","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1538-7836.2007.02590.x","article-title":"Controlled shedding of platelet glycoprotein (GP)VI and GPIb\u2010IX\u2010V by ADAM family metalloproteinases","volume":"5","author":"Gardiner","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0145","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1182\/blood-2010-05-283838","article-title":"Deciphering the human platelet sheddome","volume":"117","author":"Fong","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","article-title":"Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance","volume":"112","author":"de Maistre","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12380","article-title":"Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies","volume":"20","author":"Costa\u2010Pinto","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12967_bb0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","article-title":"A two\u2010centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen","volume":"20","author":"Stufano","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12967_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1160\/TH09-01-0032","article-title":"Novel evaluation\u00a0method for densitometric curves of von Willebrand factor multimers and a new parameter (M(MW)) to describe the degree of multimersation","volume":"102","author":"Udvardy","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0170","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12967_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS\u2010VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12967_bb0185","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2009.11.020","article-title":"Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS\u201013: a new prothrombotic mechanism in diseases associated with oxidative stress","volume":"48","author":"Lancellotti","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/jth.12967_bb0190","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2006.00975.x","article-title":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","volume":"46","author":"Jenkins","year":"2006","journal-title":"Transfusion"},{"key":"10.1111\/jth.12967_bb0195","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non\u2010surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12967_bb0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000214853","volume":"121","author":"Gadisseur","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1111\/jth.12967_bb0210","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1021\/bi0204692","article-title":"Processing of von Willebrand factor by ADAMTS\u201013","volume":"41","author":"Chung","year":"2002","journal-title":"Biochemistry"},{"key":"10.1111\/jth.12967_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0049-3848(84)90006-9","article-title":"The effect of platelet inhibitors on glycoprotein V hydrolysis by thrombin","volume":"34","author":"Knupp","year":"1984","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12967_bb0220","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/jth.12425","article-title":"Specific inhibition of ectodomain shedding of glycoprotein Ibalpha by targeting its juxtamembrane shedding cleavage site","volume":"11","author":"Liang","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bpc.2009.07.002","article-title":"Kinetic study of von Willebrand factor self\u2010aggregation induced by ristocetin","volume":"144","author":"Di Stasio","year":"2009","journal-title":"Biophys Chem"},{"key":"10.1111\/jth.12967_bb0230","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1074\/jbc.M113.511220","article-title":"Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib","volume":"289","author":"Blenner","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12967_bb0235","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1182\/blood-2004-02-0769","article-title":"Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes","volume":"104","author":"Tomer","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0240","doi-asserted-by":"crossref","first-page":"14462","DOI":"10.1074\/jbc.M500041200","article-title":"Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V","volume":"280","author":"Rabie","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12967_bb0245","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1160\/TH03-12-0795","article-title":"GPVI down\u2010regulation in murine platelets through metalloproteinase\u2010dependent shedding","volume":"91","author":"Bergmeier","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/01.WNL.0000106953.49802.9C","article-title":"Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease","volume":"62","author":"Colciaghi","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/jth.12967_bb0255","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.RES.0000143899.73453.11","article-title":"Tumor necrosis factor\u2010alpha\u2010converting enzyme (ADAM17) mediates GPIbalpha shedding\u00a0from platelets in\u00a0vitro and in\u00a0vivo","volume":"95","author":"Bergmeier","year":"2004","journal-title":"Circ Res"},{"key":"10.1111\/jth.12967_bb0260","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tibs.2005.05.006","article-title":"Shedding light on ADAM metalloproteinases","volume":"30","author":"Huovila","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1111\/jth.12967_bb0265","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnci\/djs232","article-title":"Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor","volume":"104","author":"Mochizuki","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/jth.12967_bb0270","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-07-590513","article-title":"Platelet hyaluronidase\u20102: an enzyme that translocates to the surface upon activation to function in extracellular matrix degradation","volume":"125","author":"Albeiroti","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0275","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1096\/fj.13-234864","article-title":"Unfolded protein response signaling by transcription factor XBP\u20101 regulates ADAM10 and is affected in Alzheimer's disease","volume":"28","author":"Reinhardt","year":"2014","journal-title":"FASEB J"},{"key":"10.1111\/jth.12967_bb0280","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/leu.2008.112","article-title":"Gene expression profiling distinguishes JAK2V617F\u2010negative from JAK2V617F\u2010positive patients in essential thrombocythemia","volume":"22","author":"Puigdecanet","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/jth.12967_bb0285","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1055\/s-0038-1649916","article-title":"Increased thromboxane biosynthesis in\u00a0essential thrombocythemia","volume":"74","author":"Rocca","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0290","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano\u2010Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/jth.12967_bb0295","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood-2011-02-339655","article-title":"JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients","volume":"118","author":"Panova\u2010Noeva","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0300","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2011-06-359224","article-title":"Aspirin\u2010insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target","volume":"119","author":"Pascale","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12967_bb0305","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1538-7836.2007.02387.x","article-title":"Reticulated platelets and uninhibited COX\u20101 and COX\u20102 decrease the antiplatelet effects of aspirin","volume":"5","author":"Guthikonda","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0310","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/jth.12265","article-title":"Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk\u2010guided management","volume":"11","author":"Casini","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12967_bb0315","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jacc.2013.07.110","article-title":"Response to prasugrel and levels of circulating reticulated platelets in patients with ST\u2010segment elevation myocardial infarction","volume":"63","author":"Perl","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12967_bb0320","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2012-02-406645","article-title":"Overcoming \u201caspirin resistance\u201d in MPN","volume":"119","author":"Tefferi","year":"2012","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12967","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12967","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622031142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622031142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12967\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:11:50Z","timestamp":1761534710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622031142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1538783622031142"],"URL":"https:\/\/doi.org\/10.1111\/jth.12967","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}